Info

Photocure ASA is a Norway-based pharmaceutical company that develops and sells pharmaceuticals and medical devices based on its photodynamic technology, which is used to detect and cure diseases. The Company targets the dermatology and oncology markets. Its main products comprise: Metvix, which is used for the treatment of skin cancer and pre-cancerous skin lesions; Aktilite CL 16 and CL 128, which are lamps used in photodynamic therapy (PDT) in combination with Metvix, and Hexvix, which is utilized for the detection of bladder cancer. The Company also develops photochemical internalization (PCI), a technology for light-directed drug delivery specifically into diseased cells. Photocure ASA operates through two subsidiaries PCI Biotech Holding ASA and PCI Biotech AS, and is active in Norway, Sweden, Denmark and Finland. The Company is headquartered in Oslo, Norway.